{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:47:31Z","timestamp":1792097251951,"version":"4.4.0"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":41,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.therap.2026.08.002","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:17:58Z","timestamp":1790137078000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Behavioral tics following sublingual allergen immunotherapy (OSIRIS): A case report"],"prefix":"10.1016","author":[{"given":"Ludivine","family":"Traverso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Mittaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haleh","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2026.08.002_bib0060","series-title":"D\u00e9cision no\u00a02018.0028\/DC\/SEM du 21 f\u00e9vrier 2018 du coll\u00e8ge de la Haute Autorit\u00e9 de sant\u00e9 portant adoption d\u2019une recommandation sur les allerg\u00e8nes pr\u00e9par\u00e9s sp\u00e9cialement pour un seul individu (APSI)","year":"2018"},{"key":"10.1016\/j.therap.2026.08.002_bib0065","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41577-022-00786-1","article-title":"Allergen immunotherapy: past, present and future","volume":"23","author":"Durham","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.therap.2026.08.002_bib0070","series-title":"Gamme APSI","author":"Laboratoire","year":"2018"},{"key":"10.1016\/j.therap.2026.08.002_bib0075","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1398-9995.2010.02535.x","article-title":"Immunological mechanisms of sublingual allergen-specific immunotherapy","volume":"66","author":"Novak","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.therap.2026.08.002_bib0080","doi-asserted-by":"crossref","first-page":"e2734","DOI":"10.1002\/hup.2734","article-title":"Drug-induced tics: an observational postmarketing study","volume":"35","author":"Touafchia","year":"2020","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"10.1016\/j.therap.2026.08.002_bib0085","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.therap.2026.08.002_bib0090","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2515\/therapie\/2013016","article-title":"Updating the French method for the causality assessment of adverse drug reactions","volume":"68","author":"Arimone","year":"2013","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2026.08.002_bib0095","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.therap.2022.03.001","article-title":"Pharmacovigilance and drug safety: fair prescribing and clinical research","volume":"77","author":"Montastruc","year":"2022","journal-title":"Therapie"},{"key":"10.1016\/j.therap.2026.08.002_bib0100","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12887-023-04482-4","article-title":"Tic disorder in allergic rhinitis children and adolescents: a case-control study","volume":"24","author":"Esmaeilzadeh","year":"2024","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.therap.2026.08.002_bib0105","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.neubiorev.2021.12.004","article-title":"The relationship between allergic diseases and tic disorders: a systematic review and meta-analysis","volume":"132","author":"Huang","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.therap.2026.08.002_bib0110","doi-asserted-by":"crossref","first-page":"1064001","DOI":"10.3389\/fped.2023.1064001","article-title":"The correlation between tic disorders and allergic conditions in children: a systematic review and meta-analysis of observational studies","volume":"11","author":"Chang","year":"2023","journal-title":"Front Pediatr"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595726000934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595726000934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:35:12Z","timestamp":1792096512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595726000934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":11,"alternative-id":["S0040595726000934"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2026.08.002","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Behavioral tics following sublingual allergen immunotherapy (OSIRIS): A case report","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2026.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique.","name":"copyright","label":"Copyright"}]}}